Segment Data

6 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Segment Data

Note 6 – Segment Data

The Company’s organizational structure is based upon its three principal business segments: BD Medical (“Medical”), BD Diagnostics (“Diagnostics”) and BD Biosciences (“Biosciences”). These segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. The Company evaluates performance of its business segments and allocates resources to them primarily based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses. Financial information for the Company’s segments was as follows:

	Three Months Ended March 31,						Six Months Ended March 31,
	2013			2012			2013			2012
Revenues (A)
Medical	$	1,062,071		$	1,021,187		$	2,045,444		$	1,971,584
Diagnostics		658,940			630,019			1,310,865			1,250,762
Biosciences		279,364			277,755			544,258			538,335
	$	2,000,375		$	1,928,961		$	3,900,567		$	3,760,681
Segment Operating Income
Medical	$	290,790		$	285,251		$	578,972		$	538,986
Diagnostics		144,903			158,052			314,912			323,416
Biosciences		71,403			71,267			136,445			132,423
Total Segment Operating Income		507,096			514,570			1,030,329			994,825
Unallocated Items (B)		(146,625	)		(145,045	)		(304,162	)		(302,858	)
Income from Continuing Operations Before Income Taxes	$	360,471		$	369,525		$	726,167		$	691,967

(A) Intersegment revenues are not material.

(B) Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense.

	Three Months Ended March 31,				Six Months Ended March 31,
	2013		2012		2013		2012
Revenues by Organizational Units BD Medical
Medical Surgical Systems	$	538,565	$	518,939	$	1,074,503	$	1,041,249
Diabetes Care		232,092		219,245		474,894		445,164
Pharmaceutical Systems		291,414		283,003		496,047		485,171
		1,062,071		1,021,187		2,045,444		1,971,584
BD Diagnostics
Preanalytical Systems		330,031		323,313		664,798		639,935
Diagnostic Systems		328,909		306,706		646,067		610,827
		658,940		630,019		1,310,865		1,250,762
BD Biosciences		279,364		277,755		544,258		538,335
	$	2,000,375	$	1,928,961	$	3,900,567	$	3,760,681

Revenues by geographic areas were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
	2013		2012		2013		2012
Total Revenues
United States	$	823,564	$	821,104	$	1,653,665	$	1,627,323
International		1,176,811		1,107,857		2,246,902		2,133,358
	$	2,000,375	$	1,928,961	$	3,900,567	$	3,760,681